Fennec Pharmaceuticals  logo
Fennec Pharmaceuticals FENC
$ 5.94 1.71%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Fennec Pharmaceuticals Balance Sheet 2011-2024 | FENC

Annual Balance Sheet Fennec Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

17.7 M 1.12 M - -30.3 M -13.6 M -22.8 M -28.3 M -3.93 M -942 K -2.31 M -1.66 M -2.3 M -5.3 M

Long Term Debt

30.9 M 24.9 M - - - - - - - - - - -

Long Term Debt Current

21 K - - - - - - - - - - - -

Total Non Current Liabilities

30.9 M 24.9 M 4.99 M - - - - - - - - - -

Total Current Liabilities

7.55 M 4.61 M 1.65 M 2.35 M 2.27 M 1.64 M 1.64 M 402 K 471 K 1.76 M 3.21 M 7.32 M 5.47 M

Total Liabilities

38.5 M 29.5 M 6.64 M 2.35 M 2.27 M 1.64 M 1.64 M 402 K 471 K 1.76 M 3.21 M 7.32 M 5.47 M

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-219 M -203 M -179 M - -144 M -131 M -121 M -114 M -112 M -111 M -109 M -111 M -105 M

Total Assets

26.9 M 26.9 M 22.4 M 31.4 M 14.1 M 23 M 28.4 M 3.97 M 1.02 M 2.37 M 1.75 M 2.36 M 5.35 M

Cash and Cash Equivalents

13.3 M 23.8 M 21.1 M 30.3 M 13.6 M 22.8 M 28.3 M 3.93 M 942 K 2.31 M 1.66 M 2.3 M 5.3 M

Book Value

-11.6 M -2.57 M 15.8 M 29.1 M 11.9 M 21.3 M 26.8 M 3.57 M 548 K 613 K -1.46 M -4.96 M -120 K

Total Shareholders Equity

-11.6 M -2.57 M 15.8 M 29.1 M 11.9 M 21.3 M 26.8 M 3.57 M 548 K 613 K -1.46 M -4.96 M -119 K

All numbers in USD currency

Quarterly Balance Sheet Fennec Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

32.1 M 31.8 M 31.3 M - 25.6 M 25.4 M 25.1 M - 25 M 4 M 4.5 M 5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

56.7 M 56.8 M 56.3 M 30.9 M 25.6 M 25.4 M 25.1 M 24.9 M 24.7 M 3.99 M 4.49 M 4.99 M 4.99 M 4.99 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

64.1 M 64.5 M 66.2 M 38.5 M 29.6 M 29.2 M 29.2 M 29.5 M 27.6 M 7.03 M 6.62 M 6.64 M 7 M 5.83 M - 2.35 M 2.35 M 2.35 M - 2.27 M - - - 1.64 M 2.08 M 847 K 1.17 M 1.64 M 1.64 M 1.64 M 1.64 M 402 K 402 K 402 K 402 K 471 K 471 K 471 K 471 K 1.76 M 1.76 M 1.76 M 1.76 M 3.21 M 3.21 M 3.21 M 3.21 M 7.32 M 7.32 M 7.32 M 7.32 M 5.47 M 5.47 M 5.47 M 5.47 M

Deferred Revenue

248 K 252 K 252 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-218 M -212 M -206 M -219 M -217 M -215 M -209 M -203 M -196 M -188 M -183 M -179 M -175 M -171 M -167 M -162 M -162 M -162 M -148 M -144 M -144 M -144 M -144 M -131 M -131 M -131 M -131 M -121 M -121 M -121 M -121 M -114 M -114 M -114 M -114 M -112 M -112 M -112 M -112 M -111 M -111 M -111 M -111 M -109 M - - - - - - - - - - -

Total Assets

58.9 M 63.2 M 69.2 M 26.9 M 19 M 19.4 M 21.8 M 26.9 M 30.4 M 15.6 M 19.1 M 22.4 M 26 M 28.1 M 27.8 M 31.4 M 31.4 M 31.4 M 10.4 M 14.1 M 14.1 M 14.1 M 14.1 M 23 M 23 M 23 M 23 M 28.4 M 9.89 M 28.4 M 28.4 M 3.97 M 3.97 M 3.97 M 3.97 M 1.02 M 1.02 M 1.02 M 1.02 M 2.37 M 2.37 M 2.37 M 2.37 M 1.75 M 1.75 M 1.75 M 1.75 M 2.36 M 2.36 M 2.36 M 2.36 M 5.35 M 5.35 M 5.35 M 5.35 M

Cash and Cash Equivalents

40.3 M 43.1 M 51.2 M 13.3 M 12.4 M 15 M 18.4 M 23.8 M 29.8 M 14.9 M 18.3 M 21.1 M 24.3 M 27.3 M 26.8 M 30.3 M 30.3 M 30.3 M 9.9 M 13.6 M 13.6 M 13.6 M 13.6 M 22.8 M 22.8 M 22.8 M 22.8 M 28.3 M 28.3 M 28.3 M 28.3 M 3.93 M 3.93 M 3.93 M 3.93 M 942 K 942 K 942 K 942 K 2.31 M 2.31 M 2.31 M 2.31 M 1.66 M 1.66 M 1.66 M 1.66 M 2.3 M 2.3 M 2.3 M 2.3 M 5.3 M 5.3 M 5.3 M 5.3 M

Book Value

-5.17 M -1.36 M 3.01 M -11.6 M -10.5 M -9.73 M -7.34 M -2.57 M 2.8 M 8.54 M 12.5 M 15.8 M 19 M 22.3 M 27.8 M 29.1 M 29.1 M 29.1 M 10.4 M 11.9 M 14.1 M 14.1 M 14.1 M 21.3 M 20.9 M 22.1 M 21.8 M 26.8 M 8.24 M 26.8 M 26.8 M 3.57 M 3.57 M 3.57 M 3.57 M 548 K 548 K 548 K 548 K 613 K 613 K 613 K 613 K -1.46 M -1.46 M -1.46 M -1.46 M -4.96 M -4.96 M -4.96 M -4.96 M -120 K -120 K -120 K -120 K

Total Shareholders Equity

-5.17 M -1.36 M 3.01 M -11.6 M -10.5 M -9.73 M -7.34 M -2.57 M 2.8 M 8.54 M 12.5 M 15.8 M 19 M 22.3 M 24.9 M 29.1 M 29.1 M 29.1 M 8.46 M 11.9 M 11.9 M 11.9 M 11.9 M 21.3 M 21.3 M 21.3 M 21.3 M 26.8 M 26.8 M 26.8 M 26.8 M 3.57 M 3.57 M 3.57 M 3.57 M 548 K 548 K 548 K 548 K 613 K 613 K 613 K 613 K -1.46 M -1.46 M -1.46 M -1.46 M -4.96 M -4.96 M -4.96 M -4.96 M -120 K -120 K -120 K -120 K

All numbers in USD currency